BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23204247)

  • 1. Microaneurysm turnover at the macula predicts risk of development of clinically significant macular edema in persons with mild nonproliferative diabetic retinopathy.
    Ribeiro ML; Nunes SG; Cunha-Vaz JG
    Diabetes Care; 2013 May; 36(5):1254-9. PubMed ID: 23204247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three different phenotypes of mild nonproliferative diabetic retinopathy with different risks for development of clinically significant macular edema.
    Nunes S; Ribeiro L; Lobo C; Cunha-Vaz J
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4595-604. PubMed ID: 23745006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microaneurysm formation rate as a predictive marker for progression to clinically significant macular edema in nonproliferative diabetic retinopathy.
    Haritoglou C; Kernt M; Neubauer A; Gerss J; Oliveira CM; Kampik A; Ulbig M
    Retina; 2014 Jan; 34(1):157-64. PubMed ID: 23792485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microaneurysm turnover is a biomarker for diabetic retinopathy progression to clinically significant macular edema: findings for type 2 diabetics with nonproliferative retinopathy.
    Nunes S; Pires I; Rosa A; Duarte L; Bernardes R; Cunha-Vaz J
    Ophthalmologica; 2009; 223(5):292-7. PubMed ID: 19372723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical macular edema as a predictor of progression to clinically significant macular edema in type 2 diabetes.
    Pires I; Santos AR; Nunes S; Lobo C; Cunha-Vaz J
    Ophthalmologica; 2013; 230(4):201-6. PubMed ID: 24080704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microaneurysm turnover is a predictor of diabetic retinopathy progression.
    Pappuru RKR; Ribeiro L; Lobo C; Alves D; Cunha-Vaz J
    Br J Ophthalmol; 2019 Feb; 103(2):222-226. PubMed ID: 29699981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Retinal Disease Progression in a 1-Year Longitudinal Study of Eyes With Mild Nonproliferative Retinopathy in Diabetes Type 2.
    Ribeiro L; Bandello F; Tejerina AN; Vujosevic S; Varano M; Egan C; Sivaprasad S; Menon G; Massin P; Verbraak FD; Lund-Andersen H; Martinez JP; Jürgens I; Smets E; Coriat C; Wiedemann P; Ágoas V; Querques G; Holz FG; Nunes S; Neves C; Cunha-Vaz J;
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5698-705. PubMed ID: 26322834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foveal cone function in nonproliferative diabetic retinopathy and macular edema.
    Weiner A; Christopoulos VA; Gussler CH; Adams DH; Kaufman SR; Kohn HD; Weidenthal DT
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1443-9. PubMed ID: 9191608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced depth imaging optical coherence tomography in type 2 diabetes.
    Querques G; Lattanzio R; Querques L; Del Turco C; Forte R; Pierro L; Souied EH; Bandello F
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6017-24. PubMed ID: 22879414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation between optical coherence tomographic features and severity of retinopathy, macular thickness and visual acuity in diabetic macular edema.
    Alkuraya H; Kangave D; Abu El-Asrar AM
    Int Ophthalmol; 2005 Jun; 26(3):93-9. PubMed ID: 17063373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Prevalence of Diabetic Macular Edema Based on Monocular Fundus Photography vs Optical Coherence Tomography.
    Wang YT; Tadarati M; Wolfson Y; Bressler SB; Bressler NM
    JAMA Ophthalmol; 2016 Feb; 134(2):222-8. PubMed ID: 26719967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema.
    Krepler K; Biowski R; Schrey S; Jandrasits K; Wedrich A
    Graefes Arch Clin Exp Ophthalmol; 2002 Sep; 240(9):735-8. PubMed ID: 12271370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic Retinopathy Phenotypes of Progression to Macular Edema: Pooled Analysis From Independent Longitudinal Studies of up to 2 Years' Duration.
    Cunha-Vaz J; Ribeiro L; Costa M; Simó R
    Invest Ophthalmol Vis Sci; 2017 May; 58(6):BIO206-BIO210. PubMed ID: 28785768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macular thickness measured by optical coherence tomography (OCT) in diabetic patients.
    Lattanzio R; Brancato R; Pierro L; Bandello F; Iaccher B; Fiore T; Maestranzi G
    Eur J Ophthalmol; 2002; 12(6):482-7. PubMed ID: 12510717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A screening approach to the surveillance of patients with diabetes for the presence of vision-threatening retinopathy.
    Bresnick GH; Mukamel DB; Dickinson JC; Cole DR
    Ophthalmology; 2000 Jan; 107(1):19-24. PubMed ID: 10647713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of grid decentration on macular thickness measurements in normal subjects and patients with diabetic macular edema.
    Falavarjani KG; Khadamy J; Safi H; Karimi N; Amirkourjani F
    Eur J Ophthalmol; 2015; 25(3):218-21. PubMed ID: 25449639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subclinical Macular Edema as a Predictor of Progression to Central-Involved Macular Edema in Type 2 Diabetes.
    Lobo C; Pires I; Alves D; Pappuru R; Ribeiro L; Cunha-Vaz J
    Ophthalmic Res; 2018; 60(1):18-22. PubMed ID: 29510401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year progression of diabetic subclinical macular edema in eyes with mild nonproliferative diabetic retinopathy: location of the increase in retinal thickness.
    Tejerina AN; Vujosevic S; Varano M; Egan C; Sivaprasad S; Menon G; Massin P; Verbraak FD; Lund-Andersen H; Martinez JP; Jurgens I; Smets E; Coriat C; Wiedemann P; Ágoas V; Querques G; Holz FG; Nunes S; Alves D; Neves C; Santos T; Ribeiro L; Bandello F; Cunha-Vaz J;
    Ophthalmic Res; 2015; 54(3):118-23. PubMed ID: 26315560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical coherence tomographic assessment of macular thickness and morphological patterns in diabetic macular edema: prognosis after modified grid photocoagulation.
    Shrestha A; Maharjan N; Shrestha A; Thapa R; Poudyal G
    Nepal J Ophthalmol; 2012; 4(1):128-33. PubMed ID: 22344010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of morphologic alteration correlate with vision in diabetic macular oedema: a cross-sectional evaluation of patients using the SAVE II protocol.
    Bolz M; Podkowinski D; Pretzl J; Mursch-Edlmayr AS; Luft N; Ring M;
    Acta Ophthalmol; 2020 Jun; 98(4):e400-e406. PubMed ID: 31736255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.